162 related articles for article (PubMed ID: 12803319)
21. Immunomodulatory properties of thalidomide analogs: pomalidomide and lenalidomide, experimental and therapeutic applications.
Bodera P; Stankiewicz W
Recent Pat Endocr Metab Immune Drug Discov; 2011 Sep; 5(3):192-6. PubMed ID: 21913886
[TBL] [Abstract][Full Text] [Related]
22. [Thromboembolic risk associated with use of angiogenesis inhibitors used for the treatment of cancers].
Drouet L
Pathol Biol (Paris); 2008 Jun; 56(4):195-204. PubMed ID: 18450388
[TBL] [Abstract][Full Text] [Related]
23. Development of leukocytoclastic vasculitis in a patient with multiple myeloma during treatment with thalidomide.
Witzens M; Moehler T; Neben K; Fruehauf S; Hartschuh W; Ho AD; Goldschmidt H
Ann Hematol; 2004 Jul; 83(7):467-70. PubMed ID: 14625789
[TBL] [Abstract][Full Text] [Related]
24. Thalidomide as a novel therapeutic agent: new uses for an old product.
Teo SK; Stirling DI; Zeldis JB
Drug Discov Today; 2005 Jan; 10(2):107-14. PubMed ID: 15718159
[TBL] [Abstract][Full Text] [Related]
25. Novel thalidomide analogues display anti-angiogenic activity independently of immunomodulatory effects.
Dredge K; Marriott JB; Macdonald CD; Man HW; Chen R; Muller GW; Stirling D; Dalgleish AG
Br J Cancer; 2002 Nov; 87(10):1166-72. PubMed ID: 12402158
[TBL] [Abstract][Full Text] [Related]
26. Thalidomide and lenalidomide in multiple myeloma.
Mazumder A; Jagannath S
Best Pract Res Clin Haematol; 2006; 19(4):769-80. PubMed ID: 16997182
[TBL] [Abstract][Full Text] [Related]
27. Thalidomide: present and future in multiple myeloma.
Hussein MA
Expert Rev Anticancer Ther; 2005 Feb; 5(1):25-31. PubMed ID: 15757435
[TBL] [Abstract][Full Text] [Related]
28. New drugs for myeloma.
Richardson PG; Mitsiades C; Schlossman R; Munshi N; Anderson K
Oncologist; 2007 Jun; 12(6):664-89. PubMed ID: 17602058
[TBL] [Abstract][Full Text] [Related]
29. Dermatologic and nondermatologic uses of thalidomide.
Nasca MR; Micali G; Cheigh NH; West LE; West DP
Ann Pharmacother; 2003 Sep; 37(9):1307-20. PubMed ID: 12921515
[TBL] [Abstract][Full Text] [Related]
30. Thalidomide-based treatment for HIV-associated multiple myeloma: a case report.
Aboulafia DM
AIDS Read; 2003 Aug; 13(8):383-9. PubMed ID: 14524324
[TBL] [Abstract][Full Text] [Related]
31. Antiangiogenic activity of N-substituted and tetrafluorinated thalidomide analogues.
Ng SS; Gütschow M; Weiss M; Hauschildt S; Teubert U; Hecker TK; Luzzio FA; Kruger EA; Eger K; Figg WD
Cancer Res; 2003 Jun; 63(12):3189-94. PubMed ID: 12810647
[TBL] [Abstract][Full Text] [Related]
32. [The revival of thalidomide: an old drug with new indications].
Laffitte E
Rev Prat; 2006 Nov; 56(18):1977-83. PubMed ID: 17274497
[TBL] [Abstract][Full Text] [Related]
33. [Thalidomide--new prospective therapy in oncology].
Pałgan K; Pałgan I
Wiad Lek; 2003; 56(9-10):455-9. PubMed ID: 15049211
[TBL] [Abstract][Full Text] [Related]
34. Potential new therapeutics for Waldenstrom's macroglobulinemia.
Zeldis JB; Schafer PH; Bennett BL; Mercurio F; Stirling DI
Semin Oncol; 2003 Apr; 30(2):275-81. PubMed ID: 12720152
[TBL] [Abstract][Full Text] [Related]
35. Novel therapies in myeloma.
Hayden PJ; Mitsiades CS; Anderson KC; Richardson PG
Curr Opin Hematol; 2007 Nov; 14(6):609-15. PubMed ID: 17898564
[TBL] [Abstract][Full Text] [Related]
36. Emerging data on IMiDs in the treatment of myelodysplastic syndromes (MDS).
List AF
Semin Oncol; 2005 Aug; 32(4 Suppl 5):S31-5. PubMed ID: 16085015
[TBL] [Abstract][Full Text] [Related]
37. Lenalidomide in multiple myeloma.
Richardson PG; Mitsiades C; Hideshima T; Anderson KC
Expert Rev Anticancer Ther; 2006 Aug; 6(8):1165-73. PubMed ID: 16925483
[TBL] [Abstract][Full Text] [Related]
38. Two cases of bacterial meningitis accompanied by thalidomide therapy in patients with multiple myeloma: is thalidomide associated with bacterial meningitis?
Pasa S; Altintas A; Cil T; Ustun C; Bayan K; Danis R; Urakci Z; Tuzun Y; Ayyildiz O
Int J Infect Dis; 2009 Jan; 13(1):e19-22. PubMed ID: 18621563
[TBL] [Abstract][Full Text] [Related]
39. Thalidomide and immunomodulatory drugs as cancer therapy.
Raje N; Anderson KC
Curr Opin Oncol; 2002 Nov; 14(6):635-40. PubMed ID: 12409654
[TBL] [Abstract][Full Text] [Related]
40. Lenalidomide in the treatment of multiple myeloma: a review.
Armoiry X; Aulagner G; Facon T
J Clin Pharm Ther; 2008 Jun; 33(3):219-26. PubMed ID: 18452408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
